ARTA
TGTX icon

A.R.T. Advisors’s TG Therapeutics TGTX Stock Holding History

A.R.T. Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-229,001
Closed -$2.54M – 899
2019
Q4 		$2.54M Buy
229,001
+147,100
+180% +$1.12M 0.13% 223
2019
Q3 		$460K Sell
81,901
-66,300
-45% -$462K 0.02% 894
2019
Q2 		$1.28M Sell
148,201
-101,000
-41% -$764K 0.07% 374
2019
Q1 		$2M Buy
249,201
+112,000
+82% +$605K 0.12% 234
2018
Q4 		$563K Buy
137,201
+110,382
+412% +$549K 0.04% 678
2018
Q3 		$150K Sell
26,819
-51,833
-66% -$592K 0.01% 1237
2018
Q2 		$1.03M Buy
+78,652
New +$1.08M 0.04% 623
2017
Q3 		– Sell
-58,000
Closed -$582K – 1657
2017
Q2 		$582K Buy
+58,000
New +$649K 0.03% 741
2017
Q1 		– Sell
-54,200
Closed -$252K – 1711
2016
Q4 		$252K Buy
+54,200
New +$318K 0.02% 990
2016
Q3 		– Sell
-88,654
Closed -$537K – 1136
2016
Q2 		$537K Buy
+88,654
New +$721K 0.03% 781
2016
Q1 		– Sell
-13,591
Closed -$162K – 1638
2015
Q4 		$162K Sell
13,591
-1,500
-10% -$18.9K 0.01% 1267
2015
Q3 		$152K Sell
15,091
-5,771
-28% -$86K 0.01% 1207
2015
Q2 		$346K Buy
+20,862
New +$330K 0.01% 1141
2015
Q1 		– Sell
-58,245
Closed -$922K – 1684
2014
Q4 		$922K Buy
+58,245
New +$758K 0.03% 677
2013
Q4 		– Sell
-14,268
Closed -$71K – 1505
2013
Q3 		$71K Buy
+14,268
New +$87.3K ﹤0.01% 1243

Other funds holding TGTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

A.R.T. Advisors's TGTX Position: Q1 2020 in Review

A.R.T. Advisors sold out of TG Therapeutics (TGTX) in Q1 2020, closing a stake of 229,001 shares — an estimated $2.54M sold.

A.R.T. Advisors first reported a position in TGTX in Q3 2013 and held it in 15 quarters. The position peaked at $2.54M in Q4 2019. 146 funds tracked by Wall St. Rank hold TGTX as of Q1 2020.

  • A.R.T. Advisors reported no remaining TG Therapeutics position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 229,001 TG Therapeutics shares in Q1 2020, an estimated $2.54M.
  • A.R.T. Advisors first reported a position in TG Therapeutics in Q3 2013 and held it in 15 quarters.
  • A.R.T. Advisors's TG Therapeutics position peaked at $2.54M in Q4 2019.
  • 146 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.